{"id":"https://openalex.org/W2015042489","doi":"https://doi.org/10.1111/j.1476-5381.1986.tb09490.x","title":"Effects of Bay K 8644 and nifedipine on femoral arteries of spontaneously hypertensive rats","display_name":"Effects of Bay K 8644 and nifedipine on femoral arteries of spontaneously hypertensive rats","publication_year":1986,"publication_date":"1986-05-01","ids":{"openalex":"https://openalex.org/W2015042489","doi":"https://doi.org/10.1111/j.1476-5381.1986.tb09490.x","mag":"2015042489","pmid":"https://pubmed.ncbi.nlm.nih.gov/2423174","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1917113"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1986.tb09490.x","doi":"https://doi.org/10.1111/j.1476-5381.1986.tb09490.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1986.tb09490.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1986.tb09490.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1986.tb09490.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111369990","display_name":"Kyuzo Aoki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33858575","display_name":"Nagoya City University","ror":"https://ror.org/04wn7wc95","country_code":"JP","type":"education","lineage":["https://openalex.org/I33858575"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kyuzo Aoki","raw_affiliation_strings":["Second Department of Internal Medicine, Nagoya City University Medical School, Mizuho-ku, Nagoya 467, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Department of Internal Medicine, Nagoya City University Medical School, Mizuho-ku, Nagoya 467, Japan","institution_ids":["https://openalex.org/I33858575"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110113674","display_name":"Masahisa Asano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33858575","display_name":"Nagoya City University","ror":"https://ror.org/04wn7wc95","country_code":"JP","type":"education","lineage":["https://openalex.org/I33858575"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahisa Asano","raw_affiliation_strings":["Department of Pharmacology, Nagoya City University Medical School, Mizuho-ku, Nagoya 467, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Nagoya City University Medical School, Mizuho-ku, Nagoya 467, Japan","institution_ids":["https://openalex.org/I33858575"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111369990"],"corresponding_institution_ids":["https://openalex.org/I33858575"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.714,"has_fulltext":true,"cited_by_count":61,"citation_normalized_percentile":{"value":0.84795322,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"88","issue":"1","first_page":"221","last_page":"230"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.9229000210762024,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.9229000210762024,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.03779999911785126,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.022700000554323196,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bay-k-8644","display_name":"Bay K 8644","score":0.996999979019165},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/voltage-gated-calcium-channels","display_name":"voltage-gated calcium channels","score":0.9079999923706055},{"id":"https://openalex.org/keywords/femoral-artery","display_name":"femoral artery","score":0.7960000038146973},{"id":"https://openalex.org/keywords/spontaneously-hypertensive-rats","display_name":"spontaneously hypertensive rats","score":0.9589999914169312},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6830000281333923},{"id":"https://openalex.org/keywords/vasoconstriction","display_name":"vasoconstriction","score":0.9319999814033508},{"id":"https://openalex.org/keywords/calcium-channel-blockade","display_name":"calcium channel blockade","score":0.6269999742507935},{"id":"https://openalex.org/keywords/potassium-induced-depolarization","display_name":"potassium depolarization","score":0.8659999966621399},{"id":"https://openalex.org/keywords/alpha-adrenoceptor-stimulation","display_name":"alpha-adrenoceptor stimulation","score":0.9570000171661377},{"id":"https://openalex.org/keywords/calcium-influx","display_name":"calcium influx","score":0.5410000085830688},{"id":"https://openalex.org/keywords/competitive-antagonism","display_name":"competitive antagonism","score":0.6549999713897705},{"id":"https://openalex.org/keywords/schild-plot-analysis","display_name":"Schild plot analysis","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C2779066535","wikidata":"https://www.wikidata.org/wiki/Q39111","display_name":"Nifedipine","level":3,"score":0.9219422936439514},{"id":"https://openalex.org/C2779723990","wikidata":"https://www.wikidata.org/wiki/Q707174","display_name":"Femoral artery","level":2,"score":0.741769015789032},{"id":"https://openalex.org/C163415756","wikidata":"https://www.wikidata.org/wiki/Q126473","display_name":"Contraction (grammar)","level":2,"score":0.7152771949768066},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6232216954231262},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5361170172691345},{"id":"https://openalex.org/C75214554","wikidata":"https://www.wikidata.org/wiki/Q2235423","display_name":"Schild regression","level":4,"score":0.5315423011779785},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5151175856590271},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5028595328330994},{"id":"https://openalex.org/C2781212610","wikidata":"https://www.wikidata.org/wiki/Q39094","display_name":"Dihydropyridine","level":3,"score":0.44668564200401306},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.44628000259399414},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.42552876472473145},{"id":"https://openalex.org/C2776820930","wikidata":"https://www.wikidata.org/wiki/Q9655","display_name":"Artery","level":2,"score":0.4170113205909729},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34322822093963623},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.300336629152298},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14895159006118774}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001498","descriptor_name":"3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005263","descriptor_name":"Femoral Artery","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009119","descriptor_name":"Muscle Contraction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009131","descriptor_name":"Muscle, Smooth, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011188","descriptor_name":"Potassium","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011189","descriptor_name":"Potassium Chloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011918","descriptor_name":"Rats, Inbred SHR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1986.tb09490.x","doi":"https://doi.org/10.1111/j.1476-5381.1986.tb09490.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1986.tb09490.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1986.tb09490.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1917113","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1917113","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:2423174","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2423174","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1986.tb09490.x","doi":"https://doi.org/10.1111/j.1476-5381.1986.tb09490.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1986.tb09490.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1986.tb09490.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2015042489.pdf","grobid_xml":"https://content.openalex.org/works/W2015042489.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W126330640","https://openalex.org/W1844605916","https://openalex.org/W1858697881","https://openalex.org/W1883976491","https://openalex.org/W1965900157","https://openalex.org/W1998540407","https://openalex.org/W2012187456","https://openalex.org/W2018493968","https://openalex.org/W2018847596","https://openalex.org/W2026187249","https://openalex.org/W2037783264","https://openalex.org/W2038235755","https://openalex.org/W2050313888","https://openalex.org/W2051157653","https://openalex.org/W2057971042","https://openalex.org/W2058878434","https://openalex.org/W2059448279","https://openalex.org/W2074616449","https://openalex.org/W2080075231","https://openalex.org/W2094980586","https://openalex.org/W2101574407","https://openalex.org/W2169067760","https://openalex.org/W2173520866","https://openalex.org/W2226325292","https://openalex.org/W2302863210","https://openalex.org/W2409077664","https://openalex.org/W2409976994","https://openalex.org/W2461720530","https://openalex.org/W2470216633","https://openalex.org/W3100551523"],"related_works":["https://openalex.org/W2029937626","https://openalex.org/W205295093","https://openalex.org/W2201160213","https://openalex.org/W2273243982","https://openalex.org/W1998677633","https://openalex.org/W2074616449","https://openalex.org/W2083641830","https://openalex.org/W2023340553","https://openalex.org/W2164320904","https://openalex.org/W1996880913"],"abstract_inverted_index":{"Vasoconstrictor":[0],"effects":[1],"of":[2,21,44,65,136,250],"Bay":[3,45,88,207,262],"K":[4,46,89,208,263],"8644":[5,47,90,209,264],"(an":[6],"agonist":[7,74],"known":[8],"to":[9,105,120,142,202,206,217],"increase":[10],"Ca2+":[11,16,139,183,218,252],"influx":[12],"through":[13],"the":[14,63,76,79,99,111,124,127,132,160,173,178,182,186,196,248,259],"voltage-dependent":[15,251],"channels)":[17],"on":[18],"femoral":[19,60,101,113,151,188,198,204,256],"arteries":[20,152,161,189,205],"6":[22],"week":[23],"old":[24],"spontaneously":[25],"hypertensive":[26],"rats":[27,40],"(SHR)":[28],"were":[29,123,162,210,223],"investigated,":[30],"and":[31,265],"data":[32],"compared":[33],"with":[34,164,261],"findings":[35],"in":[36,58,62,94,98,110,118,126,131,150,172,177,185,195,220,247,254],"age-matched":[37],"normotensive":[38],"Wistar-Kyoto":[39],"(WKY).":[41],"The":[42,134],"addition":[43,135],"(1":[48],"X":[49,51],"10(-10)-3":[50],"10(-7)":[52],"M)":[53],"elicited":[54],"a":[55,96,138,147,234,245],"dose-dependent":[56,148],"contraction":[57,70,97],"SHR":[59,112,128,174,187,203,255],"artery":[61,257],"absence":[64],"any":[66],"contractile":[67],"agent.":[68],"Maximum":[69],"induced":[71,81],"by":[72,82,213,227],"this":[73],"was":[75,91,107],"same":[77,125],"as":[78,129,175],"maximum":[80],"either":[83],"K+-depolarization":[84],"or":[85],"alpha-adrenoceptor":[86,121],"stimulation.":[87],"less":[92],"effective":[93],"eliciting":[95],"WKY":[100,197],"artery.":[102,114],"Increased":[103],"sensitivity":[104],"K+":[106],"also":[108,224],"observed":[109],"In":[115],"contrast,":[116],"contractions":[117],"response":[119],"stimulation":[122,260],"those":[130,176,194],"WKY.":[133,158],"nifedipine,":[137,239],"channel":[140],"antagonist,":[141],"an":[143],"unstimulated":[144],"preparation":[145],"produced":[146,169],"relaxation":[149],"from":[153,157],"SHR,":[154],"but":[155],"not":[156],"When":[159],"contracted":[163],"60":[165],"mM":[166],"K+,":[167],"nifedipine":[168],"similar":[170],"relaxations":[171],"WKY,":[179],"suggesting":[180,240],"that":[181,241],"channels":[184,253],"are":[190],"more":[191],"activated":[192],"than":[193],"arteries.":[199],"Contractile":[200,215],"responses":[201,216],"antagonized":[211,225],"competitively":[212,226],"nifedipine.":[214,228],"determined":[219],"K+-depolarized":[221],"strips":[222],"However,":[229],"Schild":[230],"plot":[231],"analysis":[232],"demonstrated":[233],"different":[235],"pA2":[236],"value":[237],"for":[238],"there":[242],"may":[243],"be":[244],"difference":[246],"state":[249],"between":[258],"K+-depolarization.":[266]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}